National Breast and Cervical Cancer Early Detection Program partnerships in action

Sanders, Latasha D.; Larkins, Teri; Boyle, John N.; George, Susan F.; Triplett, Erin W.; Leypoldt, Melissa

doi:10.1002/cncr.28827

Cited by 7 publications

(6 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Health insurance, a major consideration in countries like the USA, can present barriers as well. Cancer screening may not be free on every insurance plan or may be inaccessible to those without insurance [57,58].…”

Section: Discussionmentioning

confidence: 99%

Cancer screening attendance rates in transgender and gender-diverse patients: a systematic review and meta-analysis

Chan,

Jamieson,

Draper

et al. 2024

Preprint

View full text Add to dashboard Cite

Objectives: To examine disparities between transgender and gender-diverse (TGD) and cisgender (CG) people through analysis of attendance rates for cancer screening and compare differences between types of cancer screened. Design: Systematic review and meta-analysis. Data sources: PubMed, EMBASE [via Ovid], CINAHL Complete [via EBSCO], and Cochrane Library from inception to 30 September 2023. Methods: Studies for inclusion were case-control or cross-sectional studies with quantitative data investigating TGD adults attending any cancer screening services. Exclusion criteria were studies with participants ineligible for cancer screening or without samples from TGD individuals, qualitative data, and cancer diagnosis from symptomatic presentation or incidental findings. A modified Newcastle-Ottawa Scale was used to assess risk of bias and reports rated poor were excluded. Results were synthesised through random-effects meta-analysis and narrative synthesis. Results: Searches identified 25 eligible records, whereby 18 met risk of bias requirements. These were cross-sectional studies, including retrospective chart reviews and survey analyses, and encompassed over 14.8 million participants. The main outcomes measured were up-to-date (UTD) and lifetime (LT) attendance. Meta-analysis found differences for UTD cervical (OR=0.37, 95% CI [0.23, 0.60], p<0.0001) and mammography screening (OR=0.41, 95% CI [0.20, 0.87], p=0.02). There were no meaningful differences seen in LT results. Pooling total odds ratios for each synthesis (cervical, breast, prostate, and colorectal cancer) showed reduced attendance in TGD participants (OR=0.50, 95% CI [0.37, 0.68], p<0.0001). Narrative synthesis of seven remaining articles supported meta-analysis results, finding generally reduced screening rates in TGD versus CG participants. Conclusions: TGD individuals are overall less likely to utilise cancer screening compared to CG counterparts. The greatest disparity in attendance was seen specifically in UTD cervical screening. Limitations of this review included high risk of bias within studies, high heterogeneity, and a lack of resources for further statistical testing. Individual and structural factors such as psychological distress, socioeconomic status, and healthcare accessibility can prevent TGD people from accessing cancer screening. Bridging this gap will require consolidated efforts from healthcare systems including reviews of structural design, innovation of accessible and inclusive technology, education of HCPs, and reassessment of patient information resources. Joint production of future interventions with the TGD community is vital to improving both cancer screening experience and outcomes. Funding: This work was supported by the INSPIRE grant generously awarded to the Hull York Medical School by the Academy of Medical Sciences through the Wellcome Trust [Ref: IR5\1018]. Systematic review registration: PROSPERO CRD42022368911.

show abstract

Section: Discussionmentioning

confidence: 99%

Cancer screening attendance rates in transgender and gender-diverse patients: a systematic review and meta-analysis

Chan,

Jamieson,

Draper

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

“…National cancer screening and vaccination programmes are the two major cancer cost-effective preventive programmes commonly adopted in different countries of the world [99][100][101][102]. National screening programmes for prostate, cervical and breast cancer are the most common cancer screening programmes worldwide [101,103,104]. Unfortunately, policies on national screening programme on oral cancer are non-existence in virtually all countries of the world [60].…”

Section: Absence Of Policies On National Preventive Programmes On Hpv...mentioning

confidence: 99%

Global health trends of human papillomavirus‐associated oral cancer: A review

Kanmodi,

Amzat,

Nwafor

et al. 2023

Public Health Challenges

View full text Add to dashboard Cite

Oral cancer is a malignant neoplastic disease, it constitutes the most common cancer in the head‐and‐neck region, and it is the 16th most common and 15th deadliest cancer type affecting humans. Despite the global efforts channelled towards global cancer control, the burden of oral cancer is still increasing. Every year, several thousands of people across 195 countries/territories die of oral cancer, and only about 40%–50% of the victims of oral cancer barely survive for 5 years after diagnosis. Within the past few decades, there has been a paradigm shift in the epidemiological trend of oral cancer risk factors. Oral sex – a major route of transmission of human papillomavirus (HPV) – was found to be increasing at an alarming rate, whereas tobacco and alcohol use had been on the decline. This narrative review critically discussed the contemporary challenges facing the global eradication of HPV‐associated oral cancer, with reasonable recommendations. The challenges discussed in this review are major, ranging from clinical to public health policy issues, which include the lack of validated and inexpensive oral HPV screening and diagnostic tools, high global public illiteracy on oral HPV infection, diverse sociocultural factors, weak global research capacity on oral HPV infection and HPV‐associated oral cancer and the absence of policies across different countries on national preventive programmes on HPV‐associated oral cancer. This review also identified the need for more attention towards the prevention and control oral HPV infection and HPV‐associated oral cancers globally.

show abstract

“…Differences in cost and insurance coverage contribute significantly to disparities by affecting cancer screening uptake (Mukem, Meng, Sriplung, & Tangcharoensathien, 2015), and timing of detection (Kim, Chukwudozie, & Calhoun, 2013). The NBCCEDP was implemented to address these issues and ensure access for low-income, uninsured, and underserved women to breast and cervical cancer care (Eheman et al, 2014; Espey et al, 2014; Lantz & Mullen, 2015; Levano et al, 2014; Sanders et al, 2014; Yancy et al, 2014). NBCCEDP programs exhibit significant heterogeneity in implementation, including differences in which organizations participate/are engaged, staffing, and reimbursement processes (Lantz, Keeton, Romano, & DeGroff, 2004).…”

Section: Introductionmentioning

confidence: 99%

Adapting to a Shifting Health Care Landscape: Illinois Breast and Cervical Cancer Program Lead Agencies’ Perspectives

Molina

Miguel

Sanz

et al. 2018

Health Promotion Practice

View full text Add to dashboard Cite

Understanding how safety net programs adapt to systemic health care changes is pivotal for creating feasible recommendations for policy implementation. This study characterizes perspectives of Lead Agency (LA) coordinators of the Illinois Breast and Cervical Cancer Program (IBCCP) in response to sociopolitical changes at state and national levels. Our cross-sectional study included 29 semistructured telephone interviews between December 2015 and January 2016. Respondents indicated some changes in the priority population served, changes in referrals and clinical services, and, a continued commitment to IBCCP. Our findings suggest that IBCCP and other safety net programs will need to be flexible to meet the ongoing needs of historically vulnerable populations in a complex, shifting environment. Implications for public health practice and policy include the need to ensure that program personnel are aware of evidence-based strategies to reach different priority populations and are kept abreast of organizational and system changes that may affect referral patterns as well as the need to educate health care providers working with safety net programs about changes in the delivery and coordination of services.

show abstract

National Breast and Cervical Cancer Early Detection Program partnerships in action

Cited by 7 publications

References 8 publications

Cancer screening attendance rates in transgender and gender-diverse patients: a systematic review and meta-analysis

Cancer screening attendance rates in transgender and gender-diverse patients: a systematic review and meta-analysis

Global health trends of human papillomavirus‐associated oral cancer: A review

Adapting to a Shifting Health Care Landscape: Illinois Breast and Cervical Cancer Program Lead Agencies’ Perspectives

Contact Info

Product

Resources

About